At NIBSC we develop standards and reference materials, test medicinal products and carry out scientific research; activities that are essential for making sure the biological medicines patients receive are safe and effective.

As a centre of the Medicines and Healthcare products Regulatory Agency we play a leading role in protecting and improving public health and supporting innovation through scientific research and development.

Our collaborative, 
multi-institutional 3-year PhD studentships offer an opportunity to develop knowledge and expertise in biological medicines and gain valuable experience working in different research environments. 

Current studentship opportunities include:

Studentship titleSupervisorsDeadline

Development and characterisation of a novel vaccine for Bordetella pertussis (whooping cough)

3-year full-time DPhil studentship in collaboration with the Oxford Vaccine Group (OVG), University of Oxford. Provisional start date: 1 October 2018.

Dr Kevin Markey and Dr Barbara Bolgiano (NIBSC) and Dr. Christine Rollier (OVG)

9 March 2018

Optimisation of cross-neutralising nanobodies to influenza haemagglutinin using in vitro molecular evolution

3-year full-time studentship in collaboration with the Division of Infection and Immunity, University College London (UCL). Provisional start date: 1 October 2018. 

Dr Simon Hufton, Dr Othmar Engelhardt and Dr Mark Preston (NIBSC) and Dr Yasu Takeuchi (UCL)

9 March, 2018

Development of a novel glyco-conjugate vaccine against Group A Streptococcus

3-year full-time studentship in collaboration with the Department of Pathogen and Molecular Biology, London School of Hygiene and Tropical Medicine (LSHTM). Provisional start date: 1 October 2018. 

Dr Alexandra Shaw and Dr Fatme Mawas (NIBSC), 
Prof Brendan Wren (LSHTM)

9 March,

Mapping functionally important and stabilising regions in biotherapeutic proteins

4-year PhD project in collaboration with the Department of Biochemical Engineering, University College London (UCL). 

Dr Paul Matejtschuk (NIBSC) and Professor Paul Dalby (UCL)

29 March, 2018
If you are interested in any of the above posts or have quesitons about the application process email

Working at NIBSC

Our scientists work at the interface of industry, academia and medicines regulation, collaborating with manufacturers, regulators and control laboratories and researchers worldwide to support the use and development of biological medicines. Because of their specialist expertise, NIBSC scientists are often required to respond rapidly to public health emergencies, such as pandemic influenza, or safety issues associated with use of biologics. 

We also help to develop national and international policies related to the use of biological medicines, sharing our knowledge and expert advice with key committees and policy making bodies.  

To allow us to protect and improve public health we receive some core funding from the UK Department of Health, and also supply reference materials and undertake control testing. Our scientific research is supported by external research grant funding secured from a range of international as well as national grant awarding bodies.